香港英诺(IMD)
LOGO

英诺诊断有限公司是由香港大学衍生而出的一家生物技术公司。


公司致力于新型激素及标记物的发现及免疫检测试剂的开发。聚焦免疫代谢领域研究,尤其是糖尿病、肥胖症和心血管代谢类疾病等重大慢性病相关研究。并成功建立了“新型标记物发现-抗原抗体生产-免疫检测试剂研发-产品验证”的链条式研发生产线。


到目前为止,英诺的产品被广泛应用于全球的基础和临床研究,且时常在许多高影响因子的出版物中被引用。

 

ImmunoDiagnostics Limited (IMD) is a spin-off biotech company from the Antibody and Immunoassay Services (AIS, www.antibody.hku.hk),

The University of Hong Kong.

 

The company focuses on ImmunoMetabolism, an emerging field which studies interplay between immunological and metabolic processes, and has developed a wild range of products related to this area.

 

By far, our products have been intensively applied in both basic and clinical studies worldwide and have been frequently cited in numerous publications with high impact factors.